Nephrocare Health Services Financials

NSE: NEPHROPLUS | BSE: 544647

₹765.35

₹18.10 (2.42%)

As on 11-Sep-2026IST

Market cap

₹7,708 Cr

Revenue (TTM)

₹999 Cr

P/E Ratio

100.3

P/B Ratio

6.8

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	998.85	755.81	566.16	437.30	--	--
Total Income	1,023.36	769.92	574.72	443.26	--	--
Total Expenditure	771.88	589.18	465.27	388.70	--	--
EBITDA	226.96	166.64	100.89	48.60	--	--
Depreciation	90.67	72.47	56.11	46.88	--	--
EBIT	136.30	94.17	44.77	1.72	--	--
Interest	60.24	20.83	20.18	16.27	--	--
Other Income	24.51	14.10	8.57	5.96	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	97.47	87.44	33.16	-8.59	--	--
Provision for Tax	20.63	20.34	-1.97	3.20	--	--
Profit after Tax	76.84	67.10	35.13	-11.79	--	--
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	76.84	67.10	35.13	-11.79	--	--

Liabilities (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	1,116.49	584.11	413.71	388.63	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	21.00	107.88	126.09	86.33	--	--
Current Liabilities	299.41	283.90	242.59	174.61	--	--
Total Liabilities	1,467.32	994.42	805.65	666.23	--	--

Assets (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	597.74	430.54	392.35	325.32	--	--
Current Assets	839.17	545.36	390.03	324.26	--	--
Total Assets	1,467.32	994.42	805.65	666.23	--	--
Total Debt*	23.02	225.80	243.37	196.21	--	--
Net Current Assets	539.76	261.46	147.45	149.64	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	232.58	135.35	72.28	11.27	--	--
Cash Flow from Investing Activities	-410.44	-125.07	-50.66	-78.21	--	--
Cash from Financing Activities	157.11	54.37	26.74	59.97	--	--
Net Cash Inflow / Outflow	-20.75	64.65	48.36	-6.97	--	--

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	7.66	76.03	40.18	-13.55	--	--
Cash EPS (₹)	16.69	158.15	104.34	40.33	--	--
Adjusted Book Value (₹)	109.48	643.50	461.91	433.46	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	23.18	766.84	413.26	64.76	--	--
Free Cash Flow per Share (₹)	4.24	-30.62	-124.40	-528.57	--	--

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	16.18	14.76	8.59	1.31	--	--
ROE (%)	9.22	13.81	9.00	-3.13	--	--
ROA (%)	6.37	7.63	4.91	-1.81	--	--
EBIT Margin (%)	13.65	12.46	7.91	0.39	--	--
Net Margin (%)	7.51	8.71	6.11	-2.66	--	--
Cash Profit Margin (%)	16.77	18.47	16.12	8.02	--	--

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	32.16	33.50	29.47	--	--	--
EBIT Growth (%)	44.74	110.32	2,509.15	--	--	--
Net Profit Growth (%)	14.52	90.98	398.02	--	--	--
EPS Growth (%)	-89.93	89.25	396.48	--	--	--
Book Value Growth (%)	93.44	40.59	7.11	--	--	--

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	66.02	--	--	--	--	--
Price / Book Value	4.62	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	19.25	0.42	1.71	3.43	--	--
Close Price (₹)	506.85	--	--	--	--	--
High Price (₹)	619.05	--	--	--	--	--
Low Price (₹)	445.00	--	--	--	--	--
Market Cap (₹ Cr)	5,072.73	--	--	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.02	0.40	0.60	0.52	--	--
Short term debt to equity ratio	0.01	0.17	0.22	0.24	--	--
Current Ratio	2.80	1.92	1.61	1.86	--	--
Quick Ratio	2.69	1.83	1.50	1.71	--	--
Interest Coverage	2.62	5.20	2.64	0.47	--	--

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	31.73	35.25	35.80	36.25	--	--
Asset Turnover	0.83	0.86	0.79	0.67	--	--
Receivable days	106.58	113.27	116.42	132.30	--	--
Inventory Days	10.90	12.69	16.82	21.93	--	--
Payable days	205.92	172.42	123.18	110.84	--	--
Cash Conversion Cycle	-88.44	-46.47	10.06	43.39	--	--